| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $0.7016 ▲ +1.68% | Yesterday | $0.6851 ▼ -0.71% | Tomorrow's Cellyan Biotechnology Co. Ltd Class A Ordinary Shares (HKPD) setup is anchored to $0.6900 and targets $0.7016 (+1.68%). The near-term read is upside; watch $0.7107 / $0.6693 because daily realized volatility is about 8.00%. |
Tomorrow's Cellyan Biotechnology Co. Ltd Class A Ordinary Shares (HKPD) setup is anchored to $0.6900 and targets $0.7016 (+1.68%). The near-term read is upside; watch $0.7107 / $0.6693 because daily realized volatility is about 8.00%. | ||||
| Week | $0.7261 ▲ +5.23% | Last Week | $0.6749 ▼ -2.19% | The 7-day Cellyan Biotechnology Co. Ltd Class A Ordinary Shares model moves from $0.6749 to $0.7261 (+5.23%). It gives upside momentum context for this stock, so breaks around $0.7107 / $0.6693 matter more than a single tick. |
The 7-day Cellyan Biotechnology Co. Ltd Class A Ordinary Shares model moves from $0.6749 to $0.7261 (+5.23%). It gives upside momentum context for this stock, so breaks around $0.7107 / $0.6693 matter more than a single tick. | ||||
| Month | $0.7668 ▲ +11.13% | Last Month | $0.6577 ▼ -4.67% | The 1-month Cellyan Biotechnology Co. Ltd Class A Ordinary Shares target is $0.7668 (+11.13%), compared with the live reference near $0.6900. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Cellyan Biotechnology Co. Ltd Class A Ordinary Shares target is $0.7668 (+11.13%), compared with the live reference near $0.6900. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $0.8278 ▲ +19.98% | Last Year | $0.6321 ▼ -8.39% | The 1-year Cellyan Biotechnology Co. Ltd Class A Ordinary Shares scenario points to $0.8278 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Cellyan Biotechnology Co. Ltd Class A Ordinary Shares scenario points to $0.8278 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $0.9709 ▲ +40.71% | 5 Years Ago | $0.5720 ▼ -17.10% | The 5-year Cellyan Biotechnology Co. Ltd Class A Ordinary Shares view is $0.9709 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Cellyan Biotechnology Co. Ltd Class A Ordinary Shares view is $0.9709 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $0.6900 | Mid |
| Daily Change | -5.48% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 69% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $0.6900 | Daily Change | -5.48% |
| Market Cap | $16.21M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.